NMTC (NeuroOne Medical Technologies) Cyclically Adjusted PB Ratio: (As of Jul. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NMTC NeuroOne Medical Technologies Corp NMTC
21 GF Score
Price $1.96
! 4 Warning Signs
View Full Analysis

What is NeuroOne Medical Technologies Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


NeuroOne Medical Technologies  (NAS:NMTC) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


NeuroOne Medical Technologies Cyclically Adjusted PB Ratio Related Terms


NeuroOne Medical Technologies Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for NeuroOne Medical Technologies's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeuroOne Medical Technologies Cyclically Adjusted PB Ratio Chart

NeuroOne Medical Technologies Annual Data
Trend Dec16 Dec17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NeuroOne Medical Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NMTC vs RDGL, TANAF, MODD: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, NeuroOne Medical Technologies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeuroOne Medical Technologies Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NeuroOne Medical Technologies's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where NeuroOne Medical Technologies's Cyclically Adjusted PB Ratio falls into.


NMTC
21GF Score
NeuroOne Medical Technologies Corp NMTC
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NeuroOne Medical Technologies Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

NeuroOne Medical Technologies's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, NeuroOne Medical Technologies's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.624/330.2130*330.2130
=0.624

Current CPI (Mar. 2026) = 330.2130.

NeuroOne Medical Technologies Quarterly Data

Book Value per Share CPI Adj_Book
201606 -0.355 241.018 -0.486
201609 -0.372 241.428 -0.509
201612 -0.943 241.432 -1.290
201703 -0.372 243.801 -0.504
201706 -0.454 244.955 -0.612
201709 -8.076 246.819 -10.805
201712 -11.526 246.524 -15.439
201803 -14.634 249.554 -19.364
201806 -16.380 251.989 -21.465
201809 -8.201 252.439 -10.728
201812 -8.885 251.233 -11.678
201903 0.619 254.202 0.804
201906 -0.366 256.143 -0.472
201909 -1.651 256.759 -2.123
201912 -6.045 256.974 -7.768
202003 -6.656 258.115 -8.515
202006 -3.877 257.797 -4.966
202009 1.677 260.280 2.128
202012 1.097 260.474 1.391
202103 5.471 264.877 6.821
202106 4.434 271.696 5.389
202109 3.274 274.310 3.941
202112 5.911 278.802 7.001
202203 4.862 287.504 5.584
202206 3.934 296.311 4.384
202209 3.553 296.808 3.953
202212 3.020 296.797 3.360
202303 1.966 301.836 2.151
202306 1.317 305.109 1.425
202309 1.567 307.789 1.681
202312 1.067 306.746 1.149
202403 0.879 312.332 0.929
202406 0.649 314.175 0.682
202409 0.160 315.301 0.168
202412 0.571 315.605 0.597
202503 0.215 319.799 0.222
202506 0.985 322.561 1.008
202509 0.849 324.800 0.863
202512 0.762 324.054 0.776
202603 0.624 330.213 0.624

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


NeuroOne Medical Technologies Business Description

Address 7599 Anagram Drive, Eden Prairie, MN, USA, 55344
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
21GF Score

Get the complete analysis for NMTC

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.96
Price